中医对糖尿病肾病的理论认识源远流长,相关理论不断发展和完善,强调其病位主要在肾,病机以阴津亏损,燥热偏盛为主,总属本虚标实,其辨证分型各家纷纭,尚未统一,但中医治疗效果越来越突出,可有效改善肾功能,目前在辨证论治、单味药物治疗、经方加减、其他中医疗法治疗等多点治疗方案均取得不错疗效.
男,68岁,因“发现血糖升高8年,乏力伴体质量增加半年”于2021年11月30日收入海口市中医医院。患者自诉8年前因消瘦至当地医院就诊,查血糖约20 mmol/L,伴口干、多饮、多尿,无视物模糊、手足麻木等症状,当时诊断为“2型糖尿病(T2DM)”,予口服降糖药物治疗(具体不详)后血糖控制尚可。1年后因血糖控制不佳改为预混胰岛素每天2次注射方案,后因血糖波动逐渐调整为胰岛素“3+1”强化治疗。目前降糖方案为:门冬胰岛素早7 U、中8~9 U、晚5~6 U三餐前皮下注射+甘精胰岛素8~10 U晨起皮下注射,诉血糖控制尚可。近6个月,患者自觉乏力明显,体质量逐渐增加,半年内增重10 kg,近亲属诉其反应迟钝,口齿欠清,颜面浮肿,无发热恶寒,无咳嗽咳痰,无胸闷心慌,无腹痛腹胀,睡眠欠佳,食欲尚可,夜尿偏多,无泡沫尿,大便每2~3天1次。既往有“高血压”“冠心病”病史,目前服用氨氯地平片(2.5 mg/次,每天1次)+替米沙坦片(40 mg/次,每天1次),血压控制可;曾服用他汀类药物后出现双小腿肌肉疼痛,服阿司匹林后亦不耐受(具体不详),故停之,现长期服用芪参益气滴丸(1袋/次,每天3次)。父亲有“糖尿病”病史。
目的:探讨白虎桂枝汤加减联合秋水仙碱在急性痛风性关节炎风湿郁热证患者治疗中的应用价值及对患者血炎性指标及高凝状态的影响.方法:将急性痛风性关节炎风湿郁热证患者纳入研究,用随机数字表法分组.对照组51例采用秋水仙碱治疗,观察组51例联合白虎桂枝汤加减治疗,治疗2周后比较临床疗效.结果:治疗后观察组红细胞沉降率、白介素-1β、转化生长因子-β水平均低于对照组,相比较差异有统计学意义(P<0.05).治疗后观察组环氧化酶-2、尿酸水平均低于对照组,相比较差异有统计学意义(P<0.05).治疗后观察组纤维蛋白原、全血低切黏度、全血高切黏度等血液流变学指标水平低于对照组,相比较差异有统计学意义(P<0.05).治疗后观察组关节肿胀、关节活动障碍、疼痛等症状评分水平低于对照组,相比较差异有统计学意义(P<0.05).观察组总有效率94.12%,高于对照组的76.47%,相比较差异有统计学意义(P<0.05).观察组不良反应总发生率31.37%,对照组为27.45%,相比较差异无统计学意义(P>0.05).结论:白虎桂枝汤加减对急性痛风性关节炎风湿郁热证患者可有效减轻炎症反应,改善高凝状态、关节功能.
目的:通过临床观察治疗慢性肾炎的门诊资料,总结采用慢肾方的治疗慢性肾炎临床疗效。研究方法收集2013年1月至2015年9月我院赵化南名中医工作室门诊慢性肾炎患者30例。基础治疗控制血压伲福达,厄贝沙坦150mg/d;雷公藤多甙40mg/日,分次服。并给予慢肾方基础方加减。治疗8周。结果(1)治疗后和治疗前比较,乏力、腰酸症状积分有显著性差异(P<0.005)。(2)治疗前后比较尿蛋白尿隐血等级变化比较差异显著,有统计学意义(P<0.005)。结论益气养血、清热利湿方联合雷公藤多甙、厄贝沙坦治疗慢性肾炎,减轻临床症状,能够明显较少尿蛋白排泄,保护肾脏功能。
Professor Zhao in treating chronic renal insufficiency taking visceral syndrome differentiation as guidelines,he considered that the onset base on spleen and kidney deficiency,phlegm stasis cross resistance,intermingled deficiency and excess is the pathogenesis.Therefore,supporting the healthy energy is the fundamental method of treatment of this disease. In addition,Professor Zhao usually used promoting blood circulation to remove blood stasis drugs and purging turbidity and detoxification medicine according to syndrome differentiation of Qi-blood and excess-deficiency. Professor Zhao combination of syndrome differentiation and disease differentiation in clinical,administration to be flexible,hot packs of Chinese medicine according to syndrome differentiation,and improve the prognosis,so as to achieve good clinical efficacy.
目的探讨流行性出血热肾损害与发热期白细胞的关系及转归。方法对39例EHF患者进行临床症状分析,进行血尿素氮、血肌酐、血尿酸、尿蛋白、血白细胞、腹部超声等检查,并进行统计分析。将无明显内脏出血并且未进行血液透析治疗的患者(30例)分为2组,综合性治疗组为对照组(18例),在综合性治疗基础上加用活血化瘀针剂的为活血化瘀组(12例),比较2组血肌酐的变化情况。结果 100%EHF患者出现蛋白尿,血肌酐最高值出现在病程第(8.03±0.67)d;比血白细胞升至最高值晚约2.5d。白细胞最高值升至15×109/L左右,血肌酐在正常范围或发展至肾功能代偿期,而当白细胞最高值升高至20×109/L左右,多肾损害多发展至肾衰竭失代偿期、甚至肾功能衰竭期。活血化瘀组血肌酐最高值低于对照组。结论 EHF白细胞最高值的变化对判断肾功能损伤出现的时间、损伤程度有意义,综合性治疗加用活血化瘀针剂,疗效优于综合性治疗,可减轻肾损害的发展。
目的:现察雪芪通肾汤对糖尿病肾病大鼠TGF-β1表达的影响.方法:造模成功后进行24周给药,测24 h尿蛋白定量,取左侧肾脏,检测TGF-β1、TGF-β1 mRNA在肾组织中的表达.结果:与模型组比较,治疗组24 h尿蛋白降低(P<0.01);和模型组比较.TGF-β1半定量免疫组化分析、RT-PCR检测结果均显示,治疗组的表达低(P<0.01),治疗组之间的比较则无明显差异(P>0.05).结论:雪芪通肾汤可降低蛋白尿,可能通过抑制DN大鼠肾组织中TGF-β1的表达,发挥抗肾脏纤维化、延缓DN病程进展保护肾脏的作用.
Objective To investigate the effect of Xueqi Tongshen decoction on the expression of p38 MAPK RNA and renal function in rat with diabetic nephropathy. Methods 46 rats were randomly divided into four groups,normal group (n=10),model group (n=12),Benazepril group (n=12) and Xueqi Tongshen decoction group (n=12). Diabetic model rats induced by STZ were applied on model group,Benazepril group and Xueqi Tongshen decoction group. Rats in different groups were treated by homologous medicines.The expression of p38 MAPK RNA and renal function in rat were measured.Results Scr and BUN in Benazepril group and Xueqi Tongshen decoction group were decreased in comparison with those in model group (P<0.01). There was no difference between normal group and Xueqi Tongshen decoction group on the levels of Scr and BUN (P>0.05). The expression of p38 MAPK RNA in Benazepril group and Xueqi Tongshen decoction group was decreased in comparison with those in model group (P<0.01),increased in comparison with that in normal group (P<0.01).Conclusion Xueqi Tongshen decoction can inhibit the expression of P38 MAPK RNA in rat with diabetic nephropathy,protect kidney and delay the development of diabetic nephropathy.